{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 47,
        "end": 52
      }
    },
    {
      "id": "T5",
      "obj": "Disease",
      "span": {
        "begin": 279,
        "end": 295
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 165,
        "end": 179
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 99,
        "end": 108
      }
    },
    {
      "id": "T7",
      "obj": "Chemical",
      "span": {
        "begin": 116,
        "end": 130
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "17884271_6",
  "text": "The present results suggest that high-activity MAO-A genotypes possibly by consecutively decreased serotonin and/or norepinephrine availability negatively influence antidepressant treatment response during the first six weeks of pharmacological treatment in female patients with Major Depression ."
}
